Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses

Marion Cremoni1,2, Vesna Brglez2,3, Sandra Perez4

  • 1Service de Néphrologie-Dialyse-Transplantation, CHU de Nice, Université Côte d'Azur, Nice, France.

Frontiers in Immunology
|December 16, 2020
PubMed

Insights

Membranous nephropathy (MN) patients exhibit altered immune responses, with higher Th17 and Th2 cytokines and lower Th1/Treg cytokines. Exposure to fine particulate matter (PM2.5) is linked to this immune dysregulation and poorer disease prognosis in MN.

Area of Science:

  • Immunology
  • Environmental Health
  • Nephrology

Background:

  • Membranous nephropathy (MN) is a rare autoimmune kidney disease.
  • The immune dysregulation in MN, particularly involving T helper 17 (Th17) cells, is not well understood.
  • Fine particulate matter (PM2.5) exposure is a potential environmental factor influencing immune responses in China.

Purpose of the Study:

  • To analyze the cytokine profile in MN patients.
  • To investigate the role of environmental factors, specifically PM2.5 exposure, in immune reorientation in MN.
  • To determine the impact of immune dysregulation on MN prognosis.

Main Methods:

  • Prospective study involving 59 MN patients and 28 healthy donors.
  • Comprehensive lifestyle questionnaires and peripheral blood cell stimulation in vitro to measure cytokine production.
  • Comparison of cytokine profiles between MN patients and controls, analyzed in relation to individual PM2.5 exposure.

Main Results:

  • MN patients showed elevated Th17/Th2 cytokines (IL-17A, IL-6, IL-4) and reduced Th1/Treg cytokines (IFN-γ, IL-10) compared to healthy donors.
  • Higher IL-17A levels in MN patients correlated with increased PM2.5 exposure.
  • Th17-mediated inflammation in MN was associated with higher risks of venous thromboembolic events and disease relapse.

Conclusions:

  • MN is characterized by a pro-inflammatory Th17/Th2 immune response potentially driven by environmental factors like PM2.5.
  • Th17-mediated inflammation in MN is linked to a worse prognosis, including increased thromboembolic events and relapse.
  • Targeting cytokine imbalances may offer alternative therapeutic strategies for high-risk MN patients, as current treatments like rituximab do not affect Th17 cytokines.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
80.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.3K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
86
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
80.8K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
281